GLP-1 & Metabolic Peptides

Next-generation incretin receptor agonists studied in preclinical research for glucose homeostasis, adipose biology, and energy metabolism. Includes dual GIP/GLP-1 agonists and triple incretin agonists – the most clinically relevant class of metabolic research compounds.